Nandini Piramal flags West Asia conflict risk that could push up pharma input costs

A longer war could hit costs via petrochemical supply chains

Nandini Piramal says West Asia tensions are manageable today, but a prolonged US Israel war against Iran could raise costs for petrochemical derived products that feed parts of the pharma supply chain. Piramal Pharma is responding by diversifying sourcing and using global manufacturing. It expects stronger momentum in contract development and manufacturing, with growth from overseas sites and complex hospital generics.